Online inquiry

IVTScrip™ mRNA-Human ABRACL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8782MR)

This product GTTS-WK8782MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABRACL protein. This product can be used in Oligodendrocyte progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_021243.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 58527
UniProt ID Q9P1F3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABRACL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8782MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK21233MR IVTScrip™ mRNA-Human ANKRD62, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD62
GTTS-WK11362MR IVTScrip™ mRNA-Human ADORA3, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADORA3
GTTS-WK27343MR IVTScrip™ mRNA-Human APPL1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APPL1
GTTS-WK26891MR IVTScrip™ mRNA-Human ASAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASAP1
GTTS-WK23296MR IVTScrip™ mRNA-Human ASB15, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASB15
GTTS-WK10625MR IVTScrip™ mRNA-Human ACIN1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACIN1
GTTS-WK25573MR IVTScrip™ mRNA-Human ARFIP2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARFIP2
GTTS-WK22317MR IVTScrip™ mRNA-Human ARHGEF33, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGEF33
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →